CBGV_3D_BS.png
Size of this preview:
800 × 513 pixels
.
Other resolutions:
320 × 205 pixels
|
640 × 411 pixels
|
1,024 × 657 pixels
|
1,280 × 822 pixels
|
2,661 × 1,708 pixels
.
Summary
| Description |
English:
Cannabigerovarin (CBGV), the propyl homolog of cannabigerol (CBG), is a cannabinoid present in Cannabis. There is no observation related to the psychoactive or psychotropic effects of CBGV when consumed or inhaled. The possible benefits of cannabigerovarin in human bodies are painkilling and anti-inflammatory properties to treat conditions like fibromyalgia and arthritis, the treatment and improvement of the dry-skin syndrome, cancer treatment by reducing the growth of cancer cells in patients who have leukemia. According to the pain-relieving effects of this natural cannabinoid, it can be helpful to treat patients who were undergoing drug exposure like chemotherapy or radiation therapy. In addition, cannabigerol metabolism increases and has a better absorption from the body when paired with cannabigerovarin.
|
| Date | |
| Source | Own work |
| Author | Mplanine |
Licensing
I, the copyright holder of this work, hereby publish it under the following license:
This file is licensed under the
Creative Commons
Attribution-Share Alike 4.0 International
license.
-
You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
-
Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.